Medical Pharmaceuticals

Powered Air Purifying Respirator Market size to increase by USD 3.71 billion by 2027 with CAGR of 9.05 between 2022 – 2027; Growth of end-user industries to drive the growth

by

NEW YORK, Jan. 12, 2024 /PRNewswire/ — The powered air purifying respirator market size is set to grow by USD 1.30 billion between 2022 and 2027 and register a CAGR of 9.05%, according to Technavio’s latest market research report. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by the way of … Read more

Más precisión en el tratamiento de tumores gracias a la tecnología superconductora de ASG Superconductors

by

GINEBRA, Italia y DRESDEN, Alemania, 11 de enero de 2024 /PRNewswire/ — La tecnología superconductora MgB2 de ASG Superconductors (ASG), la cual ya se utiliza en aplicaciones energéticas y médicas, siendo el único sistema de resonancias magnéticas (IRM) MROpenEVO verdaderamente abierto del mundo, está en el corazón de la innovación mundial presentada hoy en Dresde … Read more

Global Apoptosis Assays Market Analysis Report 2023: A $5.36 Billion Market in 2022

by

DUBLIN, Jan. 5, 2024 /PRNewswire/ — The “Apoptosis Assays Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. Global Apoptosis Assays Market has valued at USD 5.36 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.70% through 2028. … Read more

CompleteCare Health Network Provides Notice of Cybersecurity Incident

by

SI DESEA RECIBIR ESTE AVISO EN ESPAÑOL, POR FAVOR MARQUE [856-451-4700]. GRACIAS BRIDGETON, N.J., Dec. 15, 2023 /PRNewswire/ — CompleteCare Health Network (CCHN) is providing notice of a recent cybersecurity incident that involved certain individuals’ personal identifiable information and personal health information. On or around October 12, 2023, CCHN detected and stopped a sophisticated ransomware … Read more

Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches

by

 Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches that are enabling patients to live longer or better, judicious uses of older treatment approaches, … Read more

REAGILA: An Atypical Antipsychotic Used in the Treatment of Schizophrenia and Manic or Mixed Episodes of Bipolar Disorder

by

DUBLIN, Dec. 8, 2023 /PRNewswire/ — The “REAGILA Drug Insight and Market Forecast – 2032” drug pipelines has been added to  ResearchAndMarkets.com’s offering. This report provides comprehensive insights about REAGILA for schizophrenia in the seven major markets. A detailed picture of the REAGILA for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and … Read more

University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States

by

BioGenCell has announced the inauguration of the fifth Phase II cell-therapy-based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States at the University of Maryland, Baltimore. This initiative is committed to dramatically reducing the incidence of amputations in patients afflicted with severe CLTI. BALTIMORE, Dec. 7, 2023 /PRNewswire/ — BioGenCell, a pioneer … Read more

Danaher Announces Quarterly Dividend

by

WASHINGTON, Dec. 5, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.24 per share of its common stock, payable on January 26, 2024 to holders of record on December 29, 2023. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics … Read more

Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection

by

STOCKHOLM, Dec. 4, 2023 /PRNewswire/ —SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that it will continue its US coast-to-coast momentum with a collaboration agreement with the Skin and Cancer Reconstructive Surgery Center (“SCARS Center”) in California. This partnership will help further introduce Nevisense to a … Read more

Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio

by

NEW YORK, Dec. 1, 2023 /PRNewswire/ — The Laryngeal Cancer Therapeutics Market size is expected to grow by USD 575.25 million, accelerating at a CAGR of almost 5.43% during the forecast period, according to Technavio Research.  The report also includes detailed analyses of the competitive landscape of the market and information about major market companies, including Accord Healthcare … Read more